Showing results (51-60 of 133) with videos related to
Sort By:
Pageof 14
Gynecologic Oncology|January 1, 2016
Improved clinical trial enrollments for uterine leiomyosarcoma patients after gynecologic oncology partnership with a sarcoma centerS E S Lange, J Liu, D R Adkins, et al.Bone Marrow Transplantation|April 1, 1999
Immune reconstitution following allogeneic peripheral blood stem cell transplantsS Shenoy, T Mohanakumar, G Todd, et al.Head & Neck|September 28, 2010
Squamous cell cancer of the head and neck with distant metastasis at presentationDavid I Kuperman, Vorachart Auethavekiat, Douglas R Adkins, et al.Cell Death & Disease|November 16, 2019
Cisplatin exposure causes c-Myc-dependent resistance to CDK4/6 inhibition in HPV-negative head and neck squamous cell carcinomaAnthony M Robinson, Richa Rathore, Nathan J Redlich, et al.Bone Marrow Transplantation|January 10, 2001
Resolution of psoriasis after allogeneic bone marrow transplantation for chronic myelogenous leukemia: late complications of therapyD R Adkins, M H Abidi, R A Brown, et al.Journal of Radiation Oncology|February 25, 2014
Prognostic value of <sup>18</sup>F-FDG PET metabolic parameters in oropharyngeal squamous cell carcinomaAdam A Garsa, Albert J Chang, Todd Dewees, et al.Head and Neck Pathology|January 8, 2015
Epidermal Growth Factor Receptor Expression in Spindle Cell Carcinomas of the Head and NeckR F Watson, R D Chernock, K H Zhang, et al.Archives of Otolaryngology--Head & Neck Surgery|July 18, 2012
Radiotherapeutic management of cervical lymph node metastases from an unknown primary siteStephanie M Perkins, Christopher R Spencer, Rebecca D Chernock, et al.Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|September 1, 1994
Phase I trial of dacarbazine with cyclophosphamide, carmustine, etoposide, and autologous stem-cell transplantation in patients with lymphoma and multiple myelomaD R Adkins, D Salzman, D Boldt, et al.The Journal of Infectious Diseases|January 1, 1997
Primary human immune response to Neisseria meningitidis serogroup C in interleukin-12-treated severe combined immunodeficient mice engrafted with human peripheral blood lymphocytesM A Westerink, D W Metzger, W A Hutchins, et al.Pageof 14